Atossa Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2013
Total Assets: $12.0M
Liabilities Breakdown FY2013
Total Liabilities: $1.4M
Asset Breakdown
Total Assets: $12.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.3M | 52.8% |
| Accounts Receivable | $139.1K | 1.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $163.1K | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $4.4M | 36.6% |
| Other Assets | $969.0K | 8.1% |
Liabilities Breakdown
Total Liabilities: $1.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $248.1K | 17.6% |
| Long-Term Debt | $5.8K | 0.4% |
| Other Liabilities | $1.2M | 82.0% |